Mereo BioPharma (MREO) Market Capitalization (2019 - 2026)

Mereo BioPharma (MREO) has reported Market Capitalization for 8 consecutive years, with $51.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 88.15% year-over-year to $51.1 million in Q2 2026; TTM through Jun 2026 was $51.1 million, a 88.15% decrease from a year earlier, with the FY2025 full-year figure at $66.5 million, down 88.05% from the prior year.
• Market Capitalization was $51.1 million for Q2 2026 at Mereo BioPharma, down from $52.7 million in the prior quarter.
• Over five years, Market Capitalization peaked at $637.6 million in Q3 2024 and troughed at $51.1 million in Q2 2026.
• A 5-year average of $280.4 million and a median of $252.5 million in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization soared 423.92% in 2024 and plunged 88.15% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $93.7 million in 2022, then soared by 245.63% to $324.0 million in 2023, then soared by 71.76% to $556.5 million in 2024, then sank by 88.05% to $66.5 million in 2025, then retreated by 23.17% to $51.1 million in 2026.
• The last three Market Capitalization figures came in at $51.1 million (Q2 2026), $52.7 million (Q1 2026), and $66.5 million (Q4 2025), per Business Quant data.